The benefit/risk ratio of low dose cyclosporin A in rheumatoid arthritis [2]

Journal of Rheumatology

Volumn 23, Issue 2, 1996, Pages 404-405

  Flipo, R M ^a   Reigneau, O ^a   Landewe, R B M ^a   The, H S G ^a   Dijkmans, B A C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; PREDNISONE;

ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS;

ADULT; ARTHRITIS, RHEUMATOID; COST-BENEFIT ANALYSIS; CYCLOSPORINE; HUMANS; MIDDLE AGED;

EID: 0029942792     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)